Steris | STE - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
3M USD 4.75B 119M 2025-12
Accuray USD 61.87M 19.3M 2025-09
Avanos Medical USD 778.2M 200K 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
CONMED USD 1.03B 24.83M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Ecolab USD 9.77B 16.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Fortive USD 6.45B 50.5M 2025-12
Getinge SEK 33.01B 2.75B 2024-12
Globus Medical USD 4.57B 174.42M 2025-12
Haemonetics USD 911.45M 62.28M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Masimo USD 721.2M 88.8M 2025-12
Olympus JPY 773.35B 39.77B 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Owens Minor USD -460.98M 31.47M 2025-12
ResMed USD 6.32B 199.61M 2025-12
Steris USD 7.15B 145.4M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12